Generic Name and Formulations:
Ketoconazole 2%; foam; contains alcohol.
Indications for EXTINA:
Topical treatment of seborrheic dermatitis in immunocompetent patients.
Apply twice daily for 4 weeks. Dispense an amount that will cover the affected area(s) into cap or other cool surface. Pick up a small amount of foam with fingertips and massage into affected area(s) until foam disappears.
<12yrs: not established.
Not for fungal infections. Avoid contact with eyes, mucous membranes. Product is flammable. Pregnancy. Nursing mothers.
Application site reactions (eg, burning), contact sensitization (eg, photoallergenicity).
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics